TrialBMC medicine2023

The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.

Lin-Quan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.